EP1030666A4 - Novel use of compounds for anti-pruritic activity - Google Patents

Novel use of compounds for anti-pruritic activity

Info

Publication number
EP1030666A4
EP1030666A4 EP98953608A EP98953608A EP1030666A4 EP 1030666 A4 EP1030666 A4 EP 1030666A4 EP 98953608 A EP98953608 A EP 98953608A EP 98953608 A EP98953608 A EP 98953608A EP 1030666 A4 EP1030666 A4 EP 1030666A4
Authority
EP
European Patent Office
Prior art keywords
compounds
novel use
pruritic activity
pruritic
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98953608A
Other languages
German (de)
French (fr)
Other versions
EP1030666A1 (en
Inventor
Don E Griswold
Siegfried Benjamin Christensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of EP1030666A1 publication Critical patent/EP1030666A1/en
Publication of EP1030666A4 publication Critical patent/EP1030666A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
EP98953608A 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity Withdrawn EP1030666A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17
US63746P 1997-10-17
PCT/US1998/021886 WO1999020280A1 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Publications (2)

Publication Number Publication Date
EP1030666A1 EP1030666A1 (en) 2000-08-30
EP1030666A4 true EP1030666A4 (en) 2002-10-16

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98953608A Withdrawn EP1030666A4 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Country Status (18)

Country Link
EP (1) EP1030666A4 (en)
JP (1) JP2001520196A (en)
KR (1) KR20010031149A (en)
CN (1) CN1306426A (en)
AR (1) AR015966A1 (en)
AU (1) AU740875B2 (en)
BR (1) BR9814080A (en)
CA (1) CA2306985A1 (en)
CO (1) CO4810374A1 (en)
CZ (1) CZ20001376A3 (en)
HU (1) HUP0003792A3 (en)
IL (1) IL135581A0 (en)
NO (1) NO20001847D0 (en)
NZ (1) NZ503551A (en)
PL (1) PL341062A1 (en)
TR (1) TR200001040T2 (en)
WO (1) WO1999020280A1 (en)
ZA (1) ZA989450B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
ATE305467T1 (en) 2001-01-31 2005-10-15 Pfizer Prod Inc ETHER DERIVATIVES SUITABLE AS INHIBITORS OF PDE4 ISOZYMES
MXPA03006886A (en) 2001-01-31 2003-11-13 Pfizer Prod Inc Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes.
SK8792003A3 (en) 2001-01-31 2004-09-08 Pfizer Prod Inc Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes and pharmaceutical composition containing them
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
EP1647274A4 (en) * 2003-07-17 2008-12-10 Ono Pharmaceutical Co Remedy for pruritus comprising piperidine derivative as the active ingredient
WO2005053672A1 (en) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. Remedy for pruritus comprising cilomilast or salt thereof as the active ingredient
JP2005187458A (en) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd Itchiness-treating agent consisting of cilomilast or its salt as active ingredient
DK1781657T3 (en) * 2004-02-14 2013-06-10 Glaxosmithkline Ip Dev Ltd MEDICINES WITH HM74A RECEPTOR ACTIVITY
JP2008137892A (en) * 2005-03-04 2008-06-19 Eisai Co Ltd Antipruritic agent
NZ565494A (en) 2005-08-10 2011-06-30 Glaxosmithkline Llc Xanthine derivatives as selective HM74A agonists
CN101389612B (en) * 2006-02-21 2011-09-21 卫材R&D管理有限公司 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
TWI404709B (en) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4-(3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
EP2123641A4 (en) 2007-02-16 2011-06-22 Eisai R&D Man Co Ltd Crystal, amorphous form and salt of methyl n-ý3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl¨terephthalamic acid
KR20100042246A (en) 2007-08-17 2010-04-23 에자이 알앤드디 매니지먼트 가부시키가이샤 Novel preparation for external use
CN102336717B (en) 2007-08-17 2013-09-18 卫材R&D管理有限公司 Quinazoline derivative
US20140121240A1 (en) 2011-06-28 2014-05-01 Maruho Co., Ltd. Novel pharmaceutical composition
MA41431B1 (en) 2015-01-30 2021-05-31 Shanton Pharma Pte Ltd Prevention or treatment of gout or uric acid disease

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997035854A1 (en) * 1996-03-26 1997-10-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel phenanthridines substituted in the 6 position
WO1997043288A1 (en) * 1996-05-15 1997-11-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel imidazopyridines
WO1998040382A1 (en) * 1997-03-07 1998-09-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel tetrazoles
WO1998041232A2 (en) * 1997-03-18 1998-09-24 Basf Aktiengesellschaft Compositions for modulating responsiveness to corticosteroids
WO1998055481A1 (en) * 1997-06-03 1998-12-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69132291T2 (en) * 1990-12-21 2000-12-14 Beecham Group Plc XANTINE DERIVATIVES

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997035854A1 (en) * 1996-03-26 1997-10-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel phenanthridines substituted in the 6 position
WO1997043288A1 (en) * 1996-05-15 1997-11-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel imidazopyridines
WO1998040382A1 (en) * 1997-03-07 1998-09-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel tetrazoles
WO1998041232A2 (en) * 1997-03-18 1998-09-24 Basf Aktiengesellschaft Compositions for modulating responsiveness to corticosteroids
WO1998055481A1 (en) * 1997-06-03 1998-12-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; COHAN, V. L. ET AL: "In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP - 80633", XP002210532, retrieved from STN Database accession no. 125:237990 CA *
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (1996), 278(3), 1356-1361, 1996 *
See also references of WO9920280A1 *

Also Published As

Publication number Publication date
ZA989450B (en) 1999-04-19
CN1306426A (en) 2001-08-01
WO1999020280A1 (en) 1999-04-29
JP2001520196A (en) 2001-10-30
NO20001847L (en) 2000-04-10
AU740875B2 (en) 2001-11-15
NZ503551A (en) 2002-05-31
IL135581A0 (en) 2001-05-20
EP1030666A1 (en) 2000-08-30
CZ20001376A3 (en) 2002-06-12
PL341062A1 (en) 2001-03-26
AR015966A1 (en) 2001-05-30
CO4810374A1 (en) 1999-06-30
TR200001040T2 (en) 2001-01-22
HUP0003792A2 (en) 2001-10-28
KR20010031149A (en) 2001-04-16
HUP0003792A3 (en) 2001-12-28
AU1093899A (en) 1999-05-10
NO20001847D0 (en) 2000-04-10
CA2306985A1 (en) 1999-04-29
BR9814080A (en) 2000-09-26

Similar Documents

Publication Publication Date Title
IL134086A0 (en) Novel spiroazabicyclic heterocyclic compounds
HUP0003792A3 (en) Novel use of compounds for anti-pruritic activity
EG24412A (en) Novel compounds
EG24041A (en) New heterocyclic compounds
EG24177A (en) Novel compounds
CZ219999A3 (en) Novel compounds exhibiting analgetic activity
PL340400A1 (en) 2-phenyl-substituted imidazotriazinones as inhibitors of phosphodiesterase
IL132170A0 (en) Novel heterocyclic compounds
CZ220099A3 (en) Novel compounds exhibiting analgetic activity
PL337738A1 (en) Novel substituted compounds of imidazole
GB9706255D0 (en) Novel compounds
PL338791A1 (en) Compounds exhibiting neuronic activity
IL113248A0 (en) Use of alpha - 1c specific compounds
IL125840A0 (en) Production of bromine compounds
GB9701674D0 (en) Use of organic compounds
ZA981920B (en) Novel heterocyclic compounds
HU9800373D0 (en) Steroide compounds of anticeptive and antiosteoporosive activity
GB9707830D0 (en) Novel compounds
PL339673A1 (en) Novel compounds suitable for use as neuroprotective agents
HU9700442D0 (en) Compounds of pharmaceutical activity
ZA983800B (en) Novel heterocyclic compounds
AUPP059897A0 (en) New use of bicozamycin
GB9722026D0 (en) Use of compounds
SI1121108T1 (en) Novel therapeutic use of compounds with beta-3-agonist activity
ZA985449B (en) Novel heterocyclic compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000508

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: SI PAYMENT 20000508

A4 Supplementary search report drawn up and despatched

Effective date: 20020902

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040503